Ken Kobayashi
Chief Tech/Sci/R&D Officer bij PYXIS ONCOLOGY, INC.
Profiel
Ken Kobayashi is currently the Chief Medical Officer at Pyxis Oncology, Inc. Prior to this, he held positions as VP-Early Oncology Development & Clinical Research at Pfizer Inc. and Senior Vice President-Clinical Development at Kinnate Biopharma, Inc. He received his undergraduate degree from the University of Washington and his doctorate from the Feinberg School of Medicine.
Actieve functies van Ken Kobayashi
| Bedrijven | Functie | Begin |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 27-11-2023 |
Eerdere bekende functies van Ken Kobayashi
| Bedrijven | Functie | Einde |
|---|---|---|
| KINNATE BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 02-03-2023 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Opleiding van Ken Kobayashi
| University of Washington | Undergraduate Degree |
| Feinberg School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| PYXIS ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
